A61K 9/2081
With microcapsules or coated microparticles according to a61k9/50
Official title: {with microcapsules or coated microparticles according to A61K9/50}
A61K9/2081 (With microcapsules or coated microparticles according to a61k9/50) appears on 838 US grants and 1,342 published applications in this corpus.
Search patents in A61K- Granted patents
- 838
- Published applications
- 1,342
- Assignees
- 539
- Inventors
- 1,997
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 11 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 11 | 0 |
| 1994 | 4 | 0 |
| 1995 | 12 | 0 |
| 1996 | 11 | 0 |
| 1997 | 15 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 22 | 0 |
| 2001 | 25 | 14 |
| 2002 | 21 | 39 |
| 2003 | 38 | 85 |
| 2004 | 19 | 78 |
| 2005 | 14 | 60 |
| 2006 | 20 | 64 |
| 2007 | 15 | 52 |
| 2008 | 10 | 61 |
| 2009 | 8 | 54 |
| 2010 | 24 | 63 |
| 2011 | 28 | 73 |
| 2012 | 36 | 40 |
| 2013 | 38 | 69 |
| 2014 | 44 | 74 |
| 2015 | 41 | 76 |
| 2016 | 28 | 67 |
| 2017 | 55 | 65 |
| 2018 | 28 | 42 |
| 2019 | 35 | 63 |
| 2020 | 43 | 37 |
| 2021 | 31 | 34 |
| 2022 | 16 | 34 |
| 2023 | 22 | 35 |
| 2024 | 18 | 24 |
| 2025 | 16 | 24 |
| 2026 | 9 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition comprising meloxicam22 Sep 2026US 12,740,988 B2Mylan Laboratories Limited
- Implantable isoxazoline pharmaceutical compositions and uses thereof4 Aug 2026US 12,697,323 B2Intervet Inc.
- Preparation method of amisulpride tablet16 Jun 2026US 12,653,790 B2HQ Pharma (Shandong) Co., Ltd.
- Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders19 May 2026US 12,629,340 B2Empros Pharma AB
- Pharmaceutical formulations comprising naltrexone and/or bupropion14 Apr 2026US 12,599,563 B1Nalpropion Pharmaceuticals LLC
- Protecting a bioactive and/or precursor thereof24 Sep 2026US 2026/0283969 A1Commonwealth Scientific and Industrial Research Organisation
- Enriched Withania somnifera Based Dietary Composition and a Method Thereof24 Sep 2026US 2026/0284137 A1Arjuna Natural Private Limited
- Pharmaceutical formulations comprising naltrexone and/or bupropion13 Aug 2026US 2026/0232599 A1Nalpropion Pharmaceuticals LLC
- Oral immediate-release formulation comprising ilaprazole with improved stability as active ingredient and method for preparing same9 Jul 2026US 2026/0191846 A1Kookmin University Industry Academy Cooperation Foundation
- Pharmaceutical composition and uses thereof21 May 2026US 2026/0137624 A1Boehringer Ingelheim International GmbH
Most cited
By later US patents
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Foam substrate and micropackaged active ingredient particle composite dispensing materials1,078US 4,828,542 ATwin Rivers Engineering · 1989
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996
- Orally administrable opioid formulations having extended duration of effect437US 5,968,551 APurdue Pharma L. P. · 1999
- Controlled release oxycodone compositions436US 5,266,331 AEuroceltique, S.A. · 1993